Akzo Nobel NV
OTC:AKZOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akzo Nobel NV
OTC:AKZOF
|
NL |
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
A
|
Asia Standard International Group Ltd
OTC:ASASF
|
HK |
|
Microport Cardioflow Medtech Corp
HKEX:2160
|
CN |
|
C
|
Carindale Property Trust
ASX:CDP
|
AU |
|
Universal Power Industry Corp
OTC:UPIN
|
US |
|
LiveOne Inc
NASDAQ:LVO
|
US |
|
HC Surgical Specialists Ltd
SGX:1B1
|
SG |
|
C
|
C banner International Holdings Ltd
HKEX:1028
|
CN |
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
KR |
|
SCS Group PLC
LSE:SCS
|
UK |
Wall Street
Price Targets
AKZOF Price Targets Summary
Akzo Nobel NV
According to Wall Street analysts, the average 1-year price target for
AKZOF
is 83.68 USD
with a low forecast of 72.09 USD and a high forecast of 95.27 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AKZOF's stock price target?
Price Target
83.68
USD
According to Wall Street analysts, the average 1-year price target for
AKZOF
is 83.68 USD
with a low forecast of 72.09 USD and a high forecast of 95.27 USD.
What is Akzo Nobel NV's Revenue forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Akzo Nobel NV's revenue is
-3%.
The projected
CAGR
for the next 3 years is
3%.
What is Akzo Nobel NV's Operating Income forecast?
Projected CAGR
19%
For the last 14 years the
compound annual growth rate for
Akzo Nobel NV's operating income is
-4%.
The projected
CAGR
for the next 3 years is
19%.
What is Akzo Nobel NV's Net Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Akzo Nobel NV's net income is
2%.
The projected
CAGR
for the next 3 years is
10%.
